Drug

(ANTIMEDIA) Last week, the Drug Enforcement Administration declined to downgrade the federal classification of cannabis from a Schedule I to a Schedule II substance, stating “science doesn’t support” the notion cannabis may be used for medical purposes.

(ANTIMEDIA) Law enforcement uses reagent drug kits, which cost about $2 a pop, to test for illegal drugs in the field. It’s a small price to pay to permanently ruin an innocent person’s life.

Drug companies don’t need to give doctors thousands of dollars in kickbacks to sway them to prescribe their medications and implant their devices. A new study published online in JAMA Internal Medicine shows that doctors who received a free meal from a pharmaceutical company were more likely to prescribe the drug the company was promoting than doctors who received no such meals.

Two drug companies, Genentech and OSI Pharmaceuticals, have agreed to pay $67 million to settle a whistleblower lawsuit accusing them of misleading doctors about the effectiveness of a cancer drug called Tarceva. – By agreeing to the settlement, neither company admitted any guilt.
Federal prosecutors in San Francisco announced the settlement on June 6, 2016.

Cancer rates are increasing, and the World Health Organization (WHO) said in 2014 that cancer cases were expected to surge 57% worldwide over the next 20 years. It’s a health crisis in the making, but scientists are warning there could be an even bigger threat to human health: antimicrobial resistance.

New research shows a 43% increase in clinical trials funded by drug companies during 2006-2014. Can you say “conflict of interest?”
Concerns have been expressed over the past few years about the independence of clinical trials, due to the funding of some trials by corporations with vested interests. New data from Johns Hopkins University suggests that this is now the norm rather than the exception. The clinical trials that allow a drug to go to market are most often funded by the pharmaceutical industry.

Portuguese pharmaceutical company Bial has been trying to get approval for a synthetic ‘cannabinoid-based’ medication to treat anxiety. Unfortunately for Bial, it seems that things apparently went very wrong.
Bial’s trial is receiving mainstream media attention, perpetuating a myth that cannabis is dangerous, but there are still huge questions about what actually happened. The molecule used in the drug trial wasn’t even from a natural cannabis plant.

Someday, couch potatoes may be able to swallow their exercise rather than having to engage in physical activity. Is this something we should really be striving for?
Researchers have found 1,000 molecular reactions to exercise, clearing the way for drug treatments that actually mimic the effects of exercise. The scientists have created a “blueprint” of these reactions. [1]

The 90 percent-plus consumers who have been vocal about wanting genetically modified organisms labeled just received a win. The MSM recently announced that the bull market is dead for biotech stocks. [1]

This week, a pharmaceutical company called Sprout Pharmaceuticals may win approval for the first ‘female Viagra’ drug to boost women’s sexual desire. [1]